PharVision Advisers’s Buckle BKE Stock Holding History

PharVision Advisers’s Portfolio BKE Stock Details BKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,292	Closed	-$369K	–	713
2025 Q3	$369K	Buy	+6,292	New	+$340K	0.21%	112

Other funds holding BKE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's BKE Position: Q4 2025 in Review

PharVision Advisers sold out of Buckle (BKE) in Q4 2025, closing a stake of 6,292 shares — an estimated $369K sold.

PharVision Advisers first reported a position in BKE in Q3 2025 and held it in 1 quarter. The position peaked at $369K in Q3 2025. 315 funds tracked by Wall St. Rank hold BKE as of Q4 2025.

PharVision Advisers reported no remaining Buckle position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 6,292 Buckle shares in Q4 2025, an estimated $369K.
PharVision Advisers first reported a position in Buckle in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Buckle position peaked at $369K in Q3 2025.
315 funds tracked by Wall St. Rank held Buckle as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.